Stock comparison
Eli Lilly
Smith & Nephew
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LLY
Eli Lilly
Market cap
$1T
Sector
Healthcare
SNN
Smith & Nephew
Market cap
$13.01B
Sector
Healthcare
Overall winner
Eli Lilly LLY
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LLY | SNN | Winner |
|---|---|---|---|
| Warren Buffett | 72B | 54C | LLY |
| Benjamin Graham | 86A | 68B | LLY |
| Philip Fisher | 86A | 45D | LLY |
| Peter Lynch | 74B | 57C | LLY |
| Joel Greenblatt | 78C | 33F | LLY |
| Charlie Munger | 85A | 47D | LLY |
| Terry Smith | 77C | 49D | LLY |
Side-by-side metrics
| Metric | LLY | SNN |
|---|---|---|
| Market cap | $1T | $13.01B |
| P/E (TTM) | 36.6x | 20.3x |
| EV/EBIT | 34.1x | 15.5x |
| ROIC (TTM) | 32.06% | 9.11% |
| Gross margin | 83.51% | 68.01% |
| Net margin | 34.98% | 10.14% |
| Revenue CAGR 5y | 23.17% | 4.34% |
| EPS CAGR 5y | 40.81% | 5.03% |
| Debt / Equity | 1.4x | 0.6x |
| Dividend yield | 0.62% | 2.62% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LLY leads on
- Market cap$1Tvs $13.01B+99%
- EPS CAGR 5y40.81%vs 5.03%+88%
- Revenue CAGR 5y23.17%vs 4.34%+81%
- ROIC (TTM)32.06%vs 9.11%+72%
SNN leads on
- Dividend yield2.62%vs 0.62%+76%
- Debt / Equity0.6xvs 1.4x+55%
- EV/EBIT15.5xvs 34.1x+55%
- P/E (TTM)20.3xvs 36.6x+44%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.